top
Search terms
Results 1 - 3 of 3 - ordered by :
Ehjournal

Aims X-VeRT is the first prospective randomized trial of a novel oral anticoagulant in patients with atrial fibrillation undergoing elective cardioversion. Methods and results We assigned 1504 ...

European Heart Journal, Cappato, Riccardo, Ezekowitz, Michael D., Klein, Allan L., Camm, A. John, Ma, Chang-Sheng, Le Heuzey, Jean-Yves, Talajic, Mario, Scanavacca, Maurício, Vardas, Panos E., ...

Date : 14/12/2014 Item size : 278462 bytes
Ehjournal

Atrial fibrillation, European Society of Cardiology, Guidelines, Anticoagulation, Novel oral anticoagulants, Left atrial appendage occlusion, Rate control, Cardioversion, Rhythm control, ...

European Heart Journal, Camm, A. John, Lip, Gregory Y.H., De Caterina, Raffaele, Savelieva, Irene, Atar, Dan, Hohnloser, Stefan H., Hindricks, Gerhard, Kirchhof, Paulus, Bax, Jeroen J., Baumgartner, ...

Date : 01/11/2012 Item size : 1026967 bytes
Ehjournal

Abstract Aims X-VeRT is the first prospective randomized trial of a novel oral anticoagulant in patients with atrial fibrillation undergoing elective cardioversion. Methods and results We assigned ...

European Heart Journal, Cappato, Riccardo, Ezekowitz, Michael D., Klein, Allan L., Camm, A. John, Ma, Chang-Sheng, Le Heuzey, Jean-Yves, Talajic, Mario, Scanavacca, Maurício, Vardas, Panos E., ...

Date : 14/12/2014